Nektar Therapeutics (NKTR)
$8.64
-0.09 (-1.03%)
| CAPS Rating |
|
|---|---|
| Open | $8.69 |
| Previous Close | $8.73 |
| Daily Range | $8.57 - $8.82 |
| 52-Week Range | $2.93 - $10.64 |
| Market Cap | $805.23M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 493,290 |
| Average Daily Volume | 665,000 |
NKTR
VS S&P 500 (SPY)
How do you think NKTR will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
NKTR Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
NKTR News and Commentary
- Abbott: Brave or Stupid? – The Motley Fool
- This Partnership Will Go No Further – The Motley Fool
- 5 Cold Stocks Heating Up – The Motley Fool
- Nektar Tastes Sweet – The Motley Fool
- UPDATE 1-Nektar's cancer drug shows promise in early trial – Reuters
- UPDATE 1-Nektar signs licensing deal with AstraZeneca – Reuters
- 4-Star Stocks on the Upswing – The Motley Fool
- Rumors and Safety Issues -- One Bad Combination – The Motley Fool
- MannKind Needs More Leaps – The Motley Fool
- 3 Stocks Ready to Roar – The Motley Fool
- Unloved Stocks Ready to Shine – The Motley Fool
- Get Ready for the Fall? – The Motley Fool
- Be Kind to MannKind – The Motley Fool
- Bristol Rolls Snake Eyes in Europe – The Motley Fool
- 10 Stocks to Shake the Market – The Motley Fool
- Buyout or Sellout? – The Motley Fool
- 10 Stocks Shaking the Market – The Motley Fool
- Small cap biotech investing in the era of underperformance – Blog at The Motley Fool
- Do These Stocks Deserve Your Support? – The Motley Fool
- Busy Day for MannKind – The Motley Fool
RSS Headlines
Fool UK
